5^th International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics December 01-02, 2016 Valencia, Spain

Massimo Cecaro was born in Macerata, Italy, in 1980. After completing the high school in humanistic studies, he moved to the University of Camerino, where he got a Master Degree in Veterinary Medicine and in University of Teramo he successfully got the Specialization. Since the age of 14, he has worked as radio speaker, tv presenter and reporter for a wide range of artistic and scientific events. At the age of 24 he obtained a qualification to practice as a Journalist and in 2007 he was admitted to the National Association of Medical Press (ASMI), where he currently hold the position of National Councilor. He is Resident Member of MJA Medical Journalists Association (London). He has been lecturer of Communication in Medical Sciences in many Universities. He has been an invited speaker at international events in the field of Public Health and Safety. He has been author of several scientific works in public health. He is also director of a prestigious Educational Centre for work safety and public health. He is actively involved in international projects to improve the role of mass-media in medical sciences, and awarded in Philadelphia, with international special recognition and also member of EFSA\s Expert Database (European Food Safety Authority).

Personalized Medicine

Jon Burroughs, MD, MBA, FACHE, FAAPL is President and CEO of The Burroughs Healthcare Consulting Network, Inc. and works with some of the nation’s top healthcare consulting organizations to provide ‘best practice’ solutions and training to healthcare organizations throughout the country in the areas of governance, physician–hospital alignment strategies, as well as ways in which physicians and management can work together in new ways to solve quality, safety, operational, and financial challenges through the creation of population health programs and clinically integrated networks.

Dr. Burroughs serves on the national faculty of the American College of Healthcare Executives and the American Association for Physician Leadership, where he has been consistently rated as one of their top speakers and educators. He is the author of “Redesign the Medical Staff Model-A Collaborative Approach (published by Health Administration Press, January, 2015 which was honored with the 2016 James A. Hamilton Award for outstanding healthcare management book.

Carlos Camps, PhD extraordinary award in 1983, won in 1989 Specialist Certification in Medical Oncology at the European Medical Oncology Society (London) and the title of Master in Molecular Biology from the Francisco de Vitoria University in Madrid. In addition, it also has the title of Specialist and Master in Management of Health Systems and Hospitals at the Polytechnic University of Valencia. He was president of the ECO Foundation (Excellence and Quality in Oncology) until last year and vice president of SAISE Committee of the Ministry of Health of the Generalitat Valenciana. He is currently evaluating the Cancer Institute of France, the Italian Society of Oncology, of Andalusia and Madrid Carlos III Institute. Dr. Camps has organized more than 120 conferences and scientific meetings, and participate in numerous research projects linked to lung cancer.

research focuses on the Cancer Research.

Vincent S. Gallicchio has 42 years experience in academic medicine and research covering experimental hematology, immunology, and developmental therapeutics for human diseases such as AIDS and cancer. He has earned national and international respect and recognition for his efforts. In a first time study reporting on academic scholarly productivity in the Journal of Clinical Laboratory Science, Gallicchio was rated the number one academic biomedical laboratory science researcher in the United States. In addition to his passion for research, Gallicchio is equally passionate to teach, mentor and advise students. He has mentored many doctoral and post-doctoral students, dozens of master’s level students and hundreds of undergraduate students both foreign and domestic, many of whom are now esteemed researchers themselves at institutions such as: Oxford University, Eastern Kentucky University, University of Cincinnati, University of Florida, University of Kentucky, University of Limpopo (South Africa), Jewish and Mercy Hospitals in Cincinnati and major pharmaceutical companies such as Procter & Gamble and Johnson & Johnson. As a board certified medical laboratory scientist by the American Society of Clinical Pathology (ASCP), Gallicchio also serves as the Clinical Laboratory Director of the Lab Tree Clinical Biochemical Research Laboratory in Greenville, SC. He also serves as a consultant to Minerals Resources International, Inc on matters related to the health benefits of trace elements; and is a consulting Vice-President of Technology Development for Conversion Laboratories, LLC, and West Columbia, SC. He has served on the faculty and academic staff at the Yale University School of Medicine, the University of Kentucky Medical Center, the University of Central Lancashire (England) and the University of Wolver hampton (England). He has served as President of Alpha Eta Honor Society, the International Society for Lithium Research, International Federation of Biomedical Laboratory Science and currently serves as Vice President of the Educational and Research Centers in Trace Elements program operated under the auspice of UNESCO.

Personalized Medicine, Cell Science, Trace Elements, Biology, Biomedical Laboratory

Irina V. Zhegalova is a member of Young Research Team under the aegis of EPMA (Brussels, EU) and ISPM (Tokyo, Japan). She is a participant and speaker at international congresses in predictive preventive and personalized medicine worldwide. Irina is an author of several articles in application of bioinformatics in personalized medicine. Nowadays Irina activity performs a research in genomics and clinical bioinformatics, interested in e-Health.

Genomics and clinical bioinformatics, interested in e-Health.

Sergey Suchkov, MD, PhD was born in 11.01.1957, a researcher-immunologist, a clinician, graduated from Astrakhan State Medical University, Russia, in 1980.Suchkov has been trained at the Institute for Medical Enzymology, The USSR Academy of Medical Sciences,National Center for Immunology (Russia), NIH, Bethesda, USA) and British Society for Immunology to cover 4 British university facilities. Since 2005, Dr Suchkov has been working as Faculty Professor of I.M. Sechenov First Moscow State Medical University and Of A.I.Evdokimov Moscow State Medical & Dental University. From 2007, Suchkov is the First Vice-President and Dean of the School of PPPM Politics and Management of the University of World Politics and Law. In 1991-1995, Dr Suchkov was a Scientific Secretary-in-Chief of the Editorial Board of the International Journal“Biomedical Science” (Russian Academy of Sciences and Royal Society of Chemistry, UK) and The International Publishing Bureau at the Presidium of the Russian Academy of Sciences. In 1995-2005, Suchkov was a Director of the Russian-American Program in Immunology of the Eye Diseases.Dr Suchkov is a member of EPMA (European Association of Predictive, Preventive and Personalized Medicine,Brussels-Bonn), a member of the NY Academy of Sciences, a member of the Editorial Boards for Open Journal of Immunology and others. Dr Suchkov is known as an author of the Concept of post-infectious clinical and immunological syndrome, co-author of a concept of abzymes and their impact into the pathogenesis of autuimmunity conditions, and as one of the pioneers in promoting the Concept of PPPM into a practical branch of health services

Predictive, Preventive and Personalized Medicine,Immunology, Medicine, Pathology

Anatoly Victorovich Skalny was born on the 12th of April, 1962 in Ivano-Frankovsk-City (Ukrain). Graduated school in Olyka village of Volynskaya oblast and medical faculty of Ivano-Frankovsk Medicine State Institute (1985) with honours. Began to carry aout scientific researches from 1979 in a student scientific society under the leadership of professor G.A. Babenko, a leading specialist in medicine elementology in Soviet Union. Ph.D. in Medicine (from 1990). Member of Council on trace elements in agriculture, biology and medicine in AS USSR and RAS (from 1987), Executive Committee of Moscow department of physicians-assistants' Society (from 1989), Boards in ecology and natural recources, science, culture and public health Political Consulting Council under the President of Russian Federation (from 1997), Member of advisory committee in ecology at Moscow City Parliament, co-founder of public movement "Healthy City - health of moscovites" (from 1998). In 1985–1991 worked as a research assistant, Junior Researcher and Researcher in department of restoration treatment of children with cerebral paralysis of Research Institute of common and justice psychiatry by V.P.Serbsky of HM USSR, department of alcoholism genetics in State Scientific Center of narcology of HM USSR. In 1988 he founded scientific-medical center "Element" that is the base to carry out researches of biosubstrates elemental content for medicine purposes during 11 years (for population, health and sanitary-hygienic organizations), scientific institutes such as Research Institute of pediatrics of RAMS, Center for perinatology, obstetrics and gynaecology of HM RF, Navy Institute of Hygiene of HM RF, colleges of medicine of Moscow, Ivanovo, Irkutsk, N.Novgorod and other cities. Center for Biotic Medicine, - autonomous non-profit organization (CBM), - was founded by A.V.Skalny in 1995 that is the unique scientific-methodical Center for problems of applied medicine elementology in RF and UIS. On the 19 of January, 2001 "Russian Society of Medicine Elementology" (RUSTEM) was founded to provide the strongest evolution of trace elements paradigm. During the period from 1982 about 200 scientific articles and thesis' were published by A.V.Skalny in special issues in Russia and abroad as well as manuals and mini-monographs in problems of practical medicine elementology. A.V. Skalny with co-authors registered 3 certificates of authorship and 3 patents of RF and Ukrain in the branch of producing new biologically active compounds of trace elements (Se, Zn) to treat and make prophylaxis of human diseases, methods of treatments of zinc deficiency states, alcohol coma and schysophrenia. To date new line in medicine and ecology, - medicine elementology, - is established by A.V. Skalny in Russia and UIS and developed successfully that studies peculiarities of human organism elemental composition in different functional states and disorders and the ways to increase organism adaptative functions with the help of trace elements metabolism correction. In SMC "Element" and CBM more than 20 Ph.D.'s and 5 D.Sc.' in medicine and biology were trained who develop different applied aspects of medicine elementology in branches of perinatology, endocrinology, urology, nephrology, labour medicine, nutrition hygiene, narcology in leaders clinics of Russia, Ukrain, Kazakhstan, Uzbekistan. In 1998-1999 production of new generation of effective major and trace elements' preparations (compounds with aspartic, spirulina) was organized under the methodic management of organizations headed by A.V. Skalny that awoke interest of specialists and consumers home and abroad. On April, 2003 A.V. Skalny opened the first chair of nutritiology and bioelementology in Russia and became its leader. From September, 2003 Bioelementology Institute, the first in the world, being founded by A.V. Skalny under support of Orenburg State University rectorate and RUSTEM, began its activity.

Internal Medicine (General Medicine)

Farid Menaa is an inter- and multi-disciplinar professional (director, professor, researcher and entrepreneur) with increasing international recognition. His strong background is mainly related to medecine, biology, pharmaceutical sciences, biochemistry, biophysics and genetics. Dr. Menaa has studied and worked for/with several reputed institutions worldwide, including Sorbonne (Paris, France), CNRS (France), INSERM (France), CEA (Ministry of Defence, France), SKCC/sanford-Burnham Medical Research Institute (USA), Schools of Medecine of Paris (France), Wuerzburg (Germany) and Campinas (Unicamp, Brazil). Among other responsibilities he carried out, Dr. Menaa has been, for several years, the R&D director of Fluorotronics, Inc. San Diego, CA, USA, a premier company specialized in fluorine chemistry and nanotechnology. Dr. Menaa was also a principal investigator in projects related to Oncology, Dermatology, Stem Cells, Genetics and Hematology. Dr. Menaa is currently an international consulting expert in healthcare and biosystems for a number of organizations and serves as an editorial board member for a large number of esteemed journals in medecine, sciences and business. Dr. Menaa holds dozen of peer-reviewed manuscripts and is a respected member of prestigious scientific/medical organizations and meetings where he is often invited as a chairman.

Medicine; Genetics; Fluorine Chemistry; Nanotechnology; Biophysics; Biochemistry

Professor Mittra obtained his medical degree from University of Delhi and is a Fellow of the Royal College of Surgeons of England and holds a PhD degree from University of London. He did his post-doctoral training with Dr Renato Dulbecco, Nobel Laureate, at the Imperial Cancer Research Laboratories in London. Professor Mittra is a multi-faceted personality. He is a breast cancer surgeon while at the same time being deeply involved in public health and basic research in cancer. Professor Mittra’s current research interests lie in the area of biology of extracellular nucleic acids and their role in ageing, inflammation, degenerative disorders and initiation and metastatis of cancer

Public health and basic research in cancer

Adrian L Lerena is the Director of the Clinical Research Center in the University Hospital Infanta Cristina en Badajoz Spain. He is also Professor of Pharmacology and Clinical Pharmacology in two Medical Schools in the University of Extremadura Spain and part time in the University of Beira Interior, Portugal. He earned his PhD at University of Extremadura in 1988 and between 1989 to 1993 did his post doc at Karolinska Institute Sweden focusing on Clinical Pharmacogenetics of antidepressant and antipsychotic drugs. His teaching experience is of more than 20 years in Spain and of about 9 years in Portugal. He has supervised more than 10 PhD thesis

Pharmacology, Personalized Medicine

Acupuncture therapist Serving in holy city ,amritsar ,india , from last 16 years at guru kirpa acupuncture and holistic care center . Spent almost 7 years in the professional study of acupuncture at ludhiana ,kolkata ,coimbatore and canada. Attended 15 national and international acupuncture conferences , in punjab , tamil nadu ,delhi , kolkata , edmonton ( canada ) , lahore ( pakistan ), philadelphia ( u.s.a. ), china . And presented acupuncture papers in 9 conferences out of them . 1.Vice chairman – the alliance of research & development traditional medicines , fudan university ,china. 2.Vice president- acupuncture science association , punjab unit , india . 3.Member - tamilnadu acupuncture council , tamil nadu , india . 4.Member - pakistan acupuncture council , pakistan

Acupuncture therapist

Andreas Scherer is the Project Director for Institute for Molecular Medicine Finland (FIMM)and previously he was a founder and CEO of Spheromics, a company focused on consultancy in biomarker development, as well as analysis and interpretation of complex biomedical datasets. Dr Scherer is a molecular and computational biologist with long experience in gene expression profiling and biomarker development and qualification. Before founding Spheromics in 2007, Dr Scherer worked in various positions for Novartis in Basel, Switzerland. In 2011 he accepted the position Bioinformatics Manager at the Australian Genome Research Facility (AGRF) in Melbourne, AU, from where he returned to Finland in 2013. Dr Scherer is author and co-author of a number of articles in peer-reviewed journals, book chapters, and editor of a book about unwanted variation in microarray datasets. He is advisory board member of the journal “OA Bioinformatics”.

Bioethics, Genomics, Biomarkers

Candida Fratazzi has worked in biomedical research for over 25 years. Prior to her full commitment to Boston Biotech Clinical Research, LLC, she served as Vice President of Clinical Research at MediVector, Inc. Dr. Fratazzi has also held management positions at Johnson & Johnson Pharmaceuticals, Altus Pharmaceuticals Inc., Shire HGT, and Vitex Inc. and Wyeth Pharmaceuticals. During her carrier, Dr. Fratazzi developed clinical strategies and plan developments for many drug candidates, presented in INDs and end-of-phase2 briefing documents. Furthermore, Dr. Fratazzi devoted a special attention to drug safety and risk management recognizing its critical value in the contest of clinical development. Her work resulted in the market approval of Tigecycline® IV (Wyeth), Velaglucerase alpha® (Shire), Replagal® in Canada, and submission of Lipoprotamase (Alnara).She is also chairman of Women in Bio of Greater Boston.